6. パーキンソン病 Parkinson disease Clinical trials / Disease details
臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05274568 (ClinicalTrials.gov) | January 31, 2022 | 1/2/2022 | Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein | Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein by [18F]UCB-2897 in Participants With Parkinson's Disease or Multi-system Atrophy | Parkinson Disease;Multisystem Atrophy;Healthy Volunteer | Drug: [18F]UCB-2897 | Invicro | NULL | Recruiting | 18 Years | N/A | All | 14 | Phase 1 | United States |